[go: up one dir, main page]

RU92016546A - GROUP OF ACTIVE SUBSTANCES FOR REGENERATIVE CHEMOTHERAPY - Google Patents

GROUP OF ACTIVE SUBSTANCES FOR REGENERATIVE CHEMOTHERAPY

Info

Publication number
RU92016546A
RU92016546A RU92016546/14A RU92016546A RU92016546A RU 92016546 A RU92016546 A RU 92016546A RU 92016546/14 A RU92016546/14 A RU 92016546/14A RU 92016546 A RU92016546 A RU 92016546A RU 92016546 A RU92016546 A RU 92016546A
Authority
RU
Russia
Prior art keywords
product
followed
units
wood
separation
Prior art date
Application number
RU92016546/14A
Other languages
Russian (ru)
Other versions
RU2104016C1 (en
Inventor
Мах Вальтер
Original Assignee
Шантал Мах
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4017091A external-priority patent/DE4017091A1/en
Application filed by Шантал Мах filed Critical Шантал Мах
Publication of RU92016546A publication Critical patent/RU92016546A/en
Application granted granted Critical
Publication of RU2104016C1 publication Critical patent/RU2104016C1/en

Links

Claims (1)

Изобретение относится к медицине, в частности к группе активных веществ молекулярной системы для восстановительной химиотерапии при вирусных инфекционных заболеваниях, характеризующейся тем, что она состоит из исходного продукта (I), получаемого при производстве обогащенных полисахаридами лигниновых единиц методом экстракции в слабой кисло-щелочной среде из дерева или древесных материалов, а также растительных клеточных культур (А) с последующим отделением нерастворимых твердых компонентов: продукта (II), получаемого при производстве низкомолекулярных обедненных полисахаридами лигноидных единиц методом водно-щелочной экстракции (рН 7 - 14) из обезуглероженного дерева или биоконвертируемых древесных материалов (В) с последующим отделением нерастворимых в щелочах твердых компонентов; продукта (III), получаемого при производстве растворимого в воде смешанного продукта полимеризации путем реакции продукта стадии (I)-богатых полисахаридами лигниновых единиц с продуктом стадии (II), обедненных полисахаридами лигноидных единиц в водно-щелочных условиях (рН 9 - 12), причем выделяют низкомолекулярные фракции этого смешанного продукта полимеризации методом ультрафильтрации при номинальном разделении от 15 до 40 кД с последующим сбрасыванием ретентата; при обработке раствора Н+ - катионообменником при рН 3 - 7,0 с последующей обработкой кислой системы, которая, в частности, может применяться как парэнтерально или локально вводимая система, предназначенная для борьбы с вирусными инфекционными заболеваниями, причем вирусы могут представлять собой ретровирусы, в частности типа вирусов ВИЧ и СПИД.The invention relates to medicine, in particular to the group of active substances of the molecular system for restorative chemotherapy for viral infectious diseases, characterized in that it consists of the original product (I) obtained in the production of lignin units enriched with polysaccharides by the method of extraction in a weak acid-base medium wood or wood materials, as well as plant cell cultures (A), followed by the separation of insoluble solid components: product (II) obtained in the manufacture low-molecular polysaccharide-depleted lignoid units by the method of water-alkaline extraction (pH 7-14) from decarburized wood or bioconvertible wood materials (B), followed by separation of solid components insoluble in alkali; product (III) obtained by producing a water-soluble mixed polymerization product by reacting the product of stage (I) - polysaccharide-rich lignin units with the product of stage (II) depleted in polysaccharides of lignoid units in aqueous alkaline conditions (pH 9-12), emit low molecular weight fractions of this mixed polymerization product by ultrafiltration at a nominal separation of 15 to 40 kD, followed by dropping the retentate; when processing a solution of H + - cation exchanger at pH 3 - 7.0, followed by treatment of the acidic system, which, in particular, can be used as a parenteral or locally injected system designed to combat viral infectious diseases, and viruses can be retroviruses, particular types of HIV and AIDS viruses.
RU92016546A 1990-05-27 1991-05-27 Method of preparing an aqueous solution containing active antiviral substances RU2104016C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEP4017091.8 1990-05-27
DE4017091A DE4017091A1 (en) 1990-05-27 1990-05-27 MOLECULE COMPOSITION SYSTEM FOR THE CONTRA-ESCALATIVE THERAPY OF VIRAL INFECTIOUS DISEASES
PCT/DE1991/000450 WO1991018616A1 (en) 1990-05-27 1991-05-27 Composite molecular system for the contra-escalatory treatment of viral infections

Publications (2)

Publication Number Publication Date
RU92016546A true RU92016546A (en) 1995-02-10
RU2104016C1 RU2104016C1 (en) 1998-02-10

Family

ID=6407309

Family Applications (1)

Application Number Title Priority Date Filing Date
RU92016546A RU2104016C1 (en) 1990-05-27 1991-05-27 Method of preparing an aqueous solution containing active antiviral substances

Country Status (17)

Country Link
US (2) US5554596A (en)
EP (1) EP0535001B1 (en)
JP (1) JP2905289B2 (en)
AT (1) ATE110275T1 (en)
AU (1) AU663684B2 (en)
BG (1) BG61154B1 (en)
CA (1) CA2084093C (en)
DE (2) DE4017091A1 (en)
DK (1) DK0535001T3 (en)
ES (1) ES2065034T3 (en)
FI (1) FI925363A (en)
HU (2) HUT68910A (en)
NO (1) NO306049B1 (en)
PL (1) PL168266B1 (en)
RO (1) RO113430B1 (en)
RU (1) RU2104016C1 (en)
WO (1) WO1991018616A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348503B1 (en) 1996-02-12 2002-02-19 Meryl J. Squires Method and topical treatment composition for herpesvirus hominis
US6355684B1 (en) 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
US6350784B1 (en) 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
DE4236346A1 (en) * 1992-10-28 1994-05-05 Chantal Dr Mach Active ingredient group, process for their preparation and their use
DE4316347C1 (en) * 1993-02-26 1994-08-18 Ina Dr Levi Process for the preparation of a pharmaceutical preparation and use thereof for the treatment of certain diseases
DE4415087A1 (en) * 1994-04-29 1995-11-09 Zschiegner Hans Joachim Dr Lignin based compsn. for use in balneotherapy, cosmetics etc
DE4417254A1 (en) * 1994-05-17 1995-11-23 Zschiegner Hans Joachim Dr Lignin based products for use in veterinary medicine or animal hygiene
FR2731162B1 (en) * 1995-03-01 1997-04-11 Oreal PROCESS FOR THE EXTRACTION OF AT LEAST ONE ACTIVE AGENT FROM INDIFFERENTIATED PLANT CELLS
US20090191288A1 (en) * 1996-02-12 2009-07-30 Squires Meryl J Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases
FR2757046B1 (en) * 1996-12-16 1999-03-05 Dior Christian Parfums USE OF AN OKOUME RESIN EXTRACT, IN THE COSMETIC AND PHARMACEUTICAL AREAS, ESPECIALLY DERMATOLOGICAL
US7498156B2 (en) 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
RU2141335C1 (en) * 1998-12-30 1999-11-20 Общество с ограниченной ответственностью "Лигфарм" Antitumor agent "olipifat" and method of its preparing
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
RU2172176C1 (en) * 2000-06-19 2001-08-20 Общество с ограниченной ответственностью "Нобель" Method of antiviral agent preparing
US6866875B2 (en) * 2001-09-26 2005-03-15 Tampa Bay Research Institute Pine cone extracts and uses thereof
US7838046B2 (en) * 2001-09-26 2010-11-23 Tampa Bay Research Institute Plant extracts and uses thereof
US6703053B2 (en) * 2001-10-24 2004-03-09 Tampa Bay Research Institute Anti-HSV agent for inhibiting replication of HSV-1 and HSV-2 and method of producing a substance having anti-HSV activity
CN1897958B (en) * 2003-12-24 2011-02-02 特拉维夫大学拉玛特有限公司 Antiviral preparations obtained from a natural cinnamon extract
RU2401117C1 (en) * 2009-04-06 2010-10-10 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Preventive drug for influenza and acute respiratory viral infection
JP2010273569A (en) * 2009-05-26 2010-12-09 Wasaburo Sato Drink and supplement each having metabolic syndrome-improving action
US20100303935A1 (en) * 2009-05-29 2010-12-02 Squires Meryl J Medicinal Composition

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185097A (en) * 1978-01-09 1980-01-22 A. H. Robins Company, Inc. Method of combating Herpes simplex viruses with lignosulfonates
JPS54154507A (en) * 1978-05-22 1979-12-05 Eisai Co Ltd Inactivating agents for hbs anitgen
ATE7854T1 (en) * 1980-03-12 1984-06-15 Walter Dr. Dipl.-Phys. Mach NEW BIOCHEMICAL SUBSTANCE, PROCESS FOR ITS PRODUCTION AND PHARMACEUTICAL PREPARATION CONTAINING THE SUBSTANCE.
JPS5939411B2 (en) * 1980-12-24 1984-09-22 野田食菌工業株式会社 anti-animal virus agent
JPS57130919A (en) * 1981-02-06 1982-08-13 Eisai Co Ltd Lignin-containing virucide
DE3206911A1 (en) * 1982-02-26 1983-09-15 Lohmann Tierernährung GmbH, 2190 Cuxhaven BIOCHEMICAL ACTIVE SUBSTANCE, THE PRODUCTION THEREOF AND SUBSTANCE CONTAINING THIS ACTIVE SUBSTANCE
DE3707909A1 (en) * 1987-03-12 1988-09-22 Ruetgerswerke Ag LOW MOLECULAR ALKALIHUMINATES, METHOD FOR THE PRODUCTION AND USE THEREOF
US4985249A (en) * 1987-06-26 1991-01-15 Hiroshi Sakagami Anti-HIV agents
US4988799A (en) * 1987-08-11 1991-01-29 Daishowa Chemicals Inc. Lignosulfonate based pharmacologic agent with anti-coagulant and anti-thrombotic activity
JP2602715B2 (en) * 1988-04-12 1997-04-23 日本製紙 株式会社 Antiviral pharmaceutical composition
US4935239A (en) * 1988-04-12 1990-06-19 Sanyo-Kokusaku Pulp Co., Ltd. Composition for antiviral medicines
CA1335259C (en) * 1989-03-31 1995-04-18 Makoto Machida Composition of spent liquor from pulping process for antiviral medicine
JPH02262524A (en) * 1989-03-31 1990-10-25 Shozo Toda Aids virus growth-inhibitory agent
JPH02286623A (en) * 1989-04-27 1990-11-26 Noda Shiyokukin Kogyo Kk Antiviral substance and production thereof
JPH03120223A (en) * 1989-10-04 1991-05-22 Sanyo Kokusaku Pulp Co Ltd Antiviral pharmaceutical composition
JP2923660B2 (en) * 1990-01-06 1999-07-26 宏 坂上 Antiviral agent
JP2938916B2 (en) * 1990-01-10 1999-08-25 日本ケミカルリサーチ株式会社 Inhibitor of herpesvirus growth and inhibitor of recurrence after latent infection

Similar Documents

Publication Publication Date Title
RU92016546A (en) GROUP OF ACTIVE SUBSTANCES FOR REGENERATIVE CHEMOTHERAPY
DK0535001T3 (en) Composite molecular system for counter-escalative therapy of viral infections
WO1990015066A3 (en) Nucleotidic sequences resulting from the retrovirus gemone of the hiv-1, hiv-2, and siv type, and their applications, in particular for the amplification of the genomes of said retroviruses and for the in vitro diagnosis of infections caused by these viruses
EP0298280A3 (en) Animal derived cell with antigenic protein introduced therein
EP0295956A2 (en) Use of a protein-bound polysaccharide for making a drug for treating AIDS.
MX165944B (en) POLYEXTROSE PURIFICATION THROUGH REVERSE OSMOSIS
AU644351B2 (en) Anti-aids viral agent and anticancer action
ES2080210T3 (en) METHOD AND SYSTEM FOR THE PREPARATION OF A MEDICAL SOLUTION, FOR EXAMPLE A DIALYSIS SOLUTION.
ATE89735T1 (en) PHARMACEUTICAL PREPARATION FOR TREATMENT OF VIRUS DISEASES WITH LIVER EXTRACT.
FR2647810B1 (en) OLIGONUCLEOTIDE PRIMERS FOR THE AMPLIFICATION OF THE GENOME OF HIV-2 AND SIV RETROVIRUSES, AND THEIR APPLICATIONS TO THE IN VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES
WO1990013281A3 (en) Method of suppressing hiv infection
FR2639830B1 (en) ANTIVIRAL COMPOSITION AND ITS APPLICATIONS
EP0315459A3 (en) Hiv incomplete particles and a method for production thereof
US5223258A (en) Antiviral disinfecting composition and method of inactivating the aids virus in vitro
Yokoyama et al. Molecular phylogeny of the human immunodeficiency and related retroviruses
RU2108804C1 (en) Preparation "locferon" for treatment and prophylaxis of viral diseases and a method of its preparing
EP0281978A3 (en) Inactivation of human immunodeficiency virus (hiv) in proteinic solutions by means of phenol
JPH0825897B2 (en) Antiviral agent
KR920006008A (en) Preparation method of bone formation promoting substance
RU97109525A (en) LOCPHERON DRUG FOR TREATMENT AND PREVENTION OF VIRAL DISEASES AND METHOD OF ITS PRODUCTION
ES2061611T3 (en) CHELATES OF ACETOACETIC ESTERS-TITANIUM CONDENSED AND PROCEDURE FOR ITS PREPARATION.
JPS63316735A (en) Antiviral agent
SU1747485A1 (en) Method of virus marburg concentration from suspension
CA2339850A1 (en) A non-cytolytic recombinant hiv-1 vaccine
GB1226743A (en)